|
2025
|
P/S
|
Pharmaceuticals preparations for the treatment of depression. Drug discovery services. |
|
|
Invention
|
Formulations of mazindol.
Formulations of mazindol having superior stability and methods of admi... |
|
2024
|
Invention
|
Derivatives of substituted morpholines and uses thereof.
A compound of Formula I includes a ster... |
|
|
Invention
|
Substituted derivatives of isoindoles and uses thereof.
Substituted derivatives of 5-(4-chloroph... |
|
|
Invention
|
Substituted derivatives of isoindoles for use in the treatment of central nervous system disorder... |
|
|
Invention
|
Method of treatment of attention deficit/hyperactivity disorder (adhd).
The invention comprises ... |
|
|
Invention
|
Substituted derivatives of isoindoles. Substituted derivatives of 5-(4-chlorophenyl)-2,3-dihydroi... |
|
|
Invention
|
Derivatives of substituted morpholines and uses thereof. A compound of Formula I includes a stere... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of diseases and disorders of the per... |
|
|
Invention
|
Derivatives of substituted morpholines and uses thereof. 1 is a substituted alkane group, a heter... |
|
2023
|
Invention
|
Formulations of viloxazine.
Modified release formulations of viloxazine and methods of administe... |
|
|
Invention
|
Method of treatment of cns disorders.
The invention comprises a method of treatment of CNS disor... |
|
|
Invention
|
Process of making derivatives of substituted morpholines. Provided here are methods of making der... |
|
2022
|
Invention
|
Osmotic drug delivery system.
An oral osmotic pharmaceutical delivery system comprises a highly ... |
|
|
Invention
|
Modified release preparations containing oxcarbazepine and derivatives thereof.
Controlled-relea... |
|
|
Invention
|
Method of treatment of attention deficit/hyperactivity disorder (adhd). The invention comprises a... |
|
2021
|
Invention
|
Methods, system, and kit for monitoring, diagnosing, and treating impulsive aggression.
The pres... |
|
|
Invention
|
Methods for producing viloxazine salts and novel polymorphs thereof.
Provided here are methods o... |
|
|
Invention
|
Stabilized formulations of cns compounds.
Formulations of molindone having superior stability an... |
|
|
Invention
|
Modified release preparations containing oxcarbazepine and derivatives thereof. Controlled-releas... |
|
2020
|
P/S
|
Pharmaceutical preparations for therapeutic use in humans, namely, for the treatment and preventi... |
|
|
Invention
|
Methods of producing molindone and its salts. The present invention is directed towards novel met... |
|
2019
|
Invention
|
Use of higher doses of modified release huperzine formulations. The present application discloses... |
|
|
Invention
|
Use of higher doses of modified release huperzine formulations. The present application dis... |
|
|
P/S
|
Web-based downloadable books, magazines, pamphlets, brochures, newsletters, all regarding living ... |
|
|
Invention
|
Method of treatment of cns disorders. The invention comprises a method of treatment of CNS disord... |
|
|
Invention
|
Method of treatment of aggression. The invention comprises a method of treatment of aggression an... |
|
2018
|
Invention
|
Stabilized formulations of cns compounds. Formulations of molindone having superior stability and... |
|
|
Invention
|
Methods for producing viloxazine salts and novel polymorphs thereof. Provided here are methods of... |
|
2017
|
P/S
|
Pharmaceuticals preparations for the treatment of central nervous system disorders |
|
|
P/S
|
Packaged information kits composed primarily of printed brochures, books, booklets, advertising m... |
|
|
Invention
|
Methods, system, and kit for monitoring, diagnosing, and treating impulsive aggression. The prese... |
|
2012
|
P/S
|
Pharmaceutical preparations or substances for the treatment and prevention of central nervous sys... |
|
2005
|
P/S
|
Chemicals and excipients used in the manufacture of pharmaceuticals, formulations which promote c... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of: central nervous disorders, namely epilepsy, Alz... |
|
|
P/S
|
Chemicals and excipients used in the manufacture of pharmaceuticals, namely, formulations which p... |
|
|
P/S
|
[ Chemicals and excipients used in the manufacture of pharmaceuticals, namely, formulations which... |
|
1999
|
P/S
|
chemical additives for use in the manufacture of pharmaceuticals, namely, formulations which perm... |
